Genetic Testing - G2 Intelligence

FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine

by Glenn S. Demby | Jun 12, 2017 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

From - Diagnostic Testing & Emerging Technologies
In what is being heralded a major milestone for personalized medicine, in late May the U.S. Food and Drug Administration (FDA) approved the first…

. . . read more

This content is for Paid Members only.
Register

Already a member? Log in here

Signs Point to Expansion of Provider-Initiated Personal Genomic Testing

by Glenn S. Demby | Jun 5, 2017 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

From - Diagnostic Testing & Emerging Technologies
Since 2013 when the U.S. Food and Drug Administration (FDA) effectively stopped direct-to-consumer personal genomic testing, there has been pent up demand among healthy individuals for…

. . . read more

This content is for Paid Members only.
Register

Already a member? Log in here